Cargando…
Antifungal pharmacodynamics: Latin America's perspective
The current increment of invasive fungal infections and the availability of new broad-spectrum antifungal agents has increased the use of these agents by non-expert practitioners, without an impact on mortality. To improve efficacy while minimizing prescription errors and to reduce the high monetary...
Autores principales: | Gonzalez, Javier M., Rodriguez, Carlos A., Agudelo, Maria, Zuluaga, Andres F., Vesga, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425464/ https://www.ncbi.nlm.nih.gov/pubmed/27821250 http://dx.doi.org/10.1016/j.bjid.2016.09.009 |
Ejemplares similares
-
Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model
por: Zuluaga, Andres F., et al.
Publicado: (2015) -
Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis
por: Gonzalez, Javier M., et al.
Publicado: (2015) -
Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics
por: Zuluaga, Andres F, et al.
Publicado: (2009) -
In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin
por: Rodriguez, Carlos A, et al.
Publicado: (2010) -
Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin
por: Agudelo, Maria, et al.
Publicado: (2019)